Summary
Preeclampsia (PE) is a major cause of the pregnancy morbidity and mortality over the world. Disorganized placentation caused by trophoblast cell abnormity is one of main risk factors to induce PE. MiR-133a-3p has been shown to contain regulatory effects on oxidative stress in the cardiomyocytes. But the effects of miR-133a-3p on oxidative stress-induced apoptosis in the trophoblast cells remain unknown. In this study, trophoblast HTR-8/SVneo cells were transfected with miR-133a-3p mimics and inhibitor. H2O2 (250 μM) treatment of cells was adopted to induce oxidative stress. A series of typical molecular and cellular experiments was subsequently performed in order to investigate this issue. It was found that miR-133a-3p overexpression attenuated the oxidative stress induced by H2O2 through reduced ROS and MDA levels and enhanced antioxidase activities in the trophoblast cells. Overexpressed miR-133a-3p was shown to relieve the oxidative stress-induced apoptosis of HTR-8/SVneo cells. At molecular levels, a direct binding effect of miR-133a-3p on BACH1 was verified. Moreover, miR-133a-3p overexpression also enhanced BACH1 downstream Nrf2/HO-1 signaling to activate antioxidant genes. It is collectively demonstrated that miR-133a-3p can relieve the oxidative stress-induced apoptosis in the trophoblast cells through the BACH1/Nrf2/HO-1 signaling pathway via targeting BACH1 directly. This regulatory mechanism of miR-133a-3p in the trophoblast cells under oxidative stress may give a new perspective for oxidative stress-induced trophoblast cell abnormality and be useful to study more pathological mechanisms of PE.
Keywords: Trophoblast cells, Preeclampsia, Oxidative stress, microRNAs, Signal transduction
Introduction
One of the major causes of the maternal and perinatal death worldwide is preeclampsia (PE) that is commonly known as a pregnancy complication (Grotegut 2016). The incidence rate of PE generally accounts for 3–5 % of all pregnancies according to the publications (Mol et al. 2016). Besides, there is a great possibility of typical PE to occur during the period from twenty weeks after gestation to two days after delivery and the usual manifestations of it include hypertension and proteinuria (Sibai and Stella 2009). Currently, the pathological causes of PE for pregnant patients are still unclear, but several risk factors which may induce it have been well identified, such as nulliparity, family history, maternal age, multiple pregnancies, obesity, diabetes and also hypertension (Al-Jameil et al. 2014, Grotegut 2016). During gestation, normal deep placentation closely relies on the capacity of trophoblast cells to differentiate and invade (Straszewski-Chavez et al. 2005, Majali-Martinez et al. 2018). Dysregulation of trophoblast cell activities may also be one of the reasons to cause PE and it has already been reported that excessive apoptosis of trophoblast cells was highly related to the PE occurrence, which can be regarded as one of the pathogenesis of it (Straszewski-Chavez et al. 2005, Yu et al. 2012). Hence, the researches focusing on the trophoblast cells have gained more and more attention in the PE pathological studies.
MicroRNAs (miRNAs) are involved in the regulations of various cellular processes at both transcriptional and translational manners (Pu et al. 2019). As a member of this huge small non-coding RNA family, miR-133a was studied a lot as a tumor suppressor in various cancer types (Ji et al. 2013, Uchida et al. 2013, Gong et al. 2015, Yang et al. 2017, Yin et al. 2019). It has been published that miR-133a promoted apoptosis in the bladder cancer (Uchida et al. 2013), esophageal cancer (Yang et al. 2017, Yin et al. 2019), gastric cancer (Gong et al. 2015) and osteosarcoma (Ji et al. 2013). But interestingly, miR-133a was shown to relieve the ischemia/reperfusion- or hypoxia-induced apoptosis in the cardiomyocytes to protect myocardium (Li et al. 2015a, Li et al. 2015b, Ren et al. 2019, Yang et al. 2020), which also provided a potential therapy for cardiac disorders. Meanwhile, it was shown that overexpression of miR-133 increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities but reduce reactive oxygen species (ROS) and malondialdehyde (MDA) levels which are all the crucial indicators of oxidation in cardiomyocytes to protect cells from apoptosis induced by oxidative stress (Kumar et al. 2002, Xu et al. 2014), indicating that miR-133 may contain certain regulatory effects on oxidative stress in the cells.
Within a couple of years, miR-133a-3p has been found to maintain a higher expression level in the fetal umbilical cord blood circulation of PE pregnant patients (Hromadnikova et al. 2017). Besides, in the placental villous trophoblast samples of intra-amniotic infection-induced preterm delivery, miR-133-3p showed an increased expression level versus that in the spontaneous preterm birth (Ackerman et al. 2016). As mentioned previously, since abnormity of trophoblast cell apoptosis may lead to PE emergence and miR-133a may regulate certain indicators to react to oxidative stress, the effects of miR-133a-3p on the oxidative stress-induced apoptosis in trophoblast cells have then attracted our interests. Here, we mainly aimed to investigate this issue and possible regulatory pathways involved in the regulations of miR-133a-3p, which may provide additional evidence to supplement the pathogenesis of PE and give a potential therapeutic perspective for PE treatment.
Methods
Cell culture and treatment
The human trophoblast cells HTR-8/SVneo were obtained from the Procell Life Science & Technology Co., Ltd. (Wuhan, China). Cells were maintained in the RPMI-1640 medium (HyClone, Logan, Utah, USA) supplemented with 5 % fetal bovine serum (FBS, Biological Industries, Kibbutz Beit-Haemek, Israel) and cultured in incubators at a constant temperature 37 °C with 5 % CO2, as previously described (Yu et al. 2012). According to the experimental grouping, cells in relevant groups were treated with 250 μM H2O2 for 0, 1, 6, 12, or 24 h to induce oxidative stress and then adopted for further experiments.
Cell transfection
Cells were seeded on 6-well-plates (4×105 per well) and cultured at 37 °C, 5 % CO2 for 24 h. Then cells in each well were treated with 2 ml serum-free medium for 1 h before transfection. In each well, 100 pmol miR-133a-3p mimics or miR-133a-3p inhibitor or their NCs (JTS Scientific, Wuhan China) were transfected into HTR-8/SVneo cells using LipofectamineTM 2000 transfection reagent (Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, USA) according to the manufacturer protocol. Besides, 50 pmol miR-133a-3p mimics and 1 μg BACH1-overexpressed plasmid (SinoBiological, Beijing, China) were used for cell co-transfection. Further incubation of 250 μM H2O2 for 24 h was performed 24 h after transfection.
Real-time PCR
The high pure total RNA rapid extraction kit (BioTek, Beijing, China) was applied to extract total RNAs from samples. All procedures were based on the manufacturer protocol. The extracted RNAs were then reverse transcribed into cDNAs via M-MLV reverse transcriptase (Takara, Beijing, China) with RNase inhibitor (Takara) under conditions of: 25 °C for 10 min, 42 °C for 50 min and 80 °C for 10 min for following BTB and CNC homology 1 (BACH1, NM_001186.4) amplification (Oligo (dT)15 primer was used), and 37 °C for 30 min, 42 °C for 30 min and 70 °C for 10 min for following miR-133a-3p amplification (Sequence of the RT primers of hsa-miR-133a-3p was: GTTGGC-TCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGCCAACCAGCTG). Followed real-time PCR reaction was performed using a total of 20 μl mixture containing 1 μl cDNA templates, 1 μl primers (10 μM, Genscript, Nanjing, China), 0.3 μl SYBR Green (BioTek) and 10 μl TaqTM HS Perfect Mix (Takara) supplemented with ddH2O. The reaction conditions of real-time PCR were 5 min at 94 °C, 40 cycles of 20 s at 94 °C, 30 s at 60 °C, and 40 s at 72 °C for subsequent BACH1 expression detection as well as 2 min at 94°C, 40 cycles of 10 s at 94 °C, 15 s at 60°C, and 15 s at 72°C for miR-133a-3p measurement. The relative expression levels of mRNA BACH1 and miR-133a-3p were calculated by 2 −ΔΔCT method, with β-actin and U6 as internal references, respectively. Besides, specific primer sequences were shown as below: BACH1-F: AGAGCCCAGAACCAG-GTCA, BACH1-R: TCAGAGTCGTCTCCCAAGC, β-actin-F: CTTAGTTGCGTTACACCCTTTCTTG, β-actin-R: CTGTCACCTTCACCGTTCCAGTTT, hsa-miR-133a-3p-F: GTTTGGTCCCCTTCAACC, hsa-miR-133a-3p-R: GCAGGGTCC-GAGGTATTC, U6-F: GCTTCGGCAGCACATATACT and U6-R: GTGCAGGGTCCGAGGTATTC.
Indicator detection kits
Several indicators involved in the oxidative stress were analyzed according to the manufacturer instructions from corresponding detection kits. MDA, total SOD (T-SOD) and GSH-Px assay kits (Nanjing Jiancheng Bioengineering Institute, China) were adopted to measure the MDA levels, SOD activities and GSH-Px activities within cells and BCA protein assay kit (Beyotime, Shanghai, China) was used to determine protein concentrations. Besides, enzyme activities of caspase-3 and caspase-9 were detected using the caspase-3 activity assay kit (Beyotime) and caspase-9 activity assay kit (Solarbio, Beijing, China) respectively, combined with the Bradford protein assay kit (Beyotime) detection for protein concentrations.
Cell counting kit-8 (CCK-8) assay
HTR-8/SVneo cells were seeded onto 96-well-plates (3×103 cells per well) for cell viability detection and each group contained five replicates. After 24 h of cell transfection and following 24 h of H2O2 (250 μM) incubation, each well was added 100 μl complete medium and 10 μl CCK-8 reagents (Sigma-Aldrich, Darmstadt, Germany) for 1 h culturing at 37 °C, 5 % CO2. Optical density values (OD) of cells were detected at 450 nm through a microplate reader (BIOTEK, Winooski, VT, USA).
Flow cytometry
The ROS assay kit (Keygen Biotech, Nanjing, China) was adopted to measure ROS levels of HTR-8/SVneo cells through a fluorescence probe DCFH-DA according to the manufacturer protocol, which was then detected by flow cytometry (NovoCyte Flow Cytometers, Acea Biosciences, San Diego, CA, USA). For cell apoptosis analysis, Annexin V-FITC apoptosis detection kit (Beyotime) was used to double stain transfected cells through Annexin V-FITC and Propidium Iodide (PI) based on the manufacturer protocol, followed by fluorescence checking via NovoCyte Flow Cytometers. Besides, mitochondrial membrane potential assay kit with JC-1 (Solarbio) was applied, according to the manufacturer protocol, to observe the alterations of mitochondrial membrane potential using flow cytometry.
Western blot (WB)
Strong RIPA lysis buffer (Beyotime) was used to extract total proteins of samples and mitochondrial protein extraction kit (BOSTER, Wuhan, China) was applied to extract mitochondrial proteins from samples. All procedures were in accordance with corresponding manufacturer protocols. Protein quantification was performed through enhanced BCA protein assay kit (Beyotime) and then a certain amount of protein samples (15 μl, 15-30 μg) was loaded into gels to perform SDS-PAGE. Separated protein bands were then transformed onto PVDF membranes (Invitrogen, Carlsbad, CA, USA) through a “sandwich” structure. Prepared 5 % (M/V) BSA (Biosharp, Hefei, China) was used to block membranes before incubation of membranes with primary antibodies at 4 °C overnight. After washing with TBST, membranes were incubated with secondary antibodies at 37 °C for 40 min. ECL chemiluminescence reagents (7-sea Biotech, Shanghai, China) were added on the membranes, followed by protein band scanning and analyzing through Gel-Pro-Analyzer software. Besides, specific information of primary antibodies was shown as below: Bcl-2 (1:500, Cat. No. 12789-1-AP, Proteintech, Wuhan, China), Bax (1:500, Cat. No. 50599-2-Ig, Proteintech), cytochrome C (1:1000, Cat. No. #4272, Cell Signaling Technology, Danvers, MA, USA), BACH1 (1:500, Cat. No. A5393, Abclonal, Wuhan, China), nuclear factor-erythroid 2-related factor2 (Nrf2, 1:500, Cat. No. 16396-1-AP, Proteintech) and Heme oxygenase-1 (HO-1, 1:1000, Cat. No. 27282-1-AP, Proteintech). Internal references were: COX IV (1:500, Cat. No. 11242-1-AP, Proteintech) for mitochondrial cytochrome C, Histone H3 (1:500, Cat. No. 17168-1-AP, Proteintech) for nucleus Nrf2, and β-actin (1:2000, Cat. No. 60008-1-Ig, Proteintech) for others. Secondary Goat Anti-Mouse IgG-HRP (1:10000, Cat. No. SA00001-1, Proteintech) was applied for β-actin and secondary Goat Anti-Rabbit IgG-HRP (1:10000, Cat. No. SA00001-2, Proteintech) was used for others.
Dual luciferase reporter assay
Dual luciferase assay was performed to detect the binding effects of miR-133a-3p on BACH1 in HTR-8/SVneo cells. Cells were seeded on 12-well-plates and carried out starvation treatment for 1 h when cell confluence was around 70 % before transfection. Luciferase reporter vectors pmirGLO (Promega, Madison, Wisconsin, USA) containing wildtype (wt-BACH1: 5′-CCTTGAGAGTATATGGGGACCAGT-3′) or mutant (mt-BACH1: 5′-CCTTGAGAGTATATGGCCTGG-TGT-3′) 3′UTR of BACH1 and miR-133a-3p mimics or NC mimics were co-transfected into cells using LipofectamineTM 2000 transfection reagent (Invitrogen), followed by further luciferase activity detection through a Dual luciferase reporter assay kit (Promega) according to the manufacturer protocol.
Statistical analysis
All experiments were performed at least three times and the figures were showed as mean ± standard deviation (SD). One-way ANOVA analysis in Graphpad Prism 8 (GraphPad Software, San Diego, CA, USA) was applied to analyze the differences between multiple groups, combined with the Turkey multiple comparison test. Besides, a statistically significant difference in this study was adopted as P<0.05.
Results
MiR-133a-3p alleviates the oxidative stress induced by H2O2 in HTR-8/SVneo cells
In order to investigate the alterations of miR-133a-3p and BACH1 in the trophoblast HTR-8/SVneo cells treated with 250 μM H2O2 for different time, real-time PCR was performed 0, 1, 6, 12, and 24 h after H2O2 incubation to evaluate relative mRNA levels of both miR-133a-3p and BACH1. It was shown that miR-133a-3p level was reduced significantly at 6 h after H2O2 treatment compared to cells without H2O2 treating, and the longer the H2O2 processing, the lower the miR-133a-3p would be (Fig. 1A). However, BACH1 expression showed apposite tendency, which was increased obviously after H2O2 treatment over time (Fig. 1A). To have a better understanding of miR-133a-3p regulation on H2O2-exposed trophoblast cells, HTR-8/SVneo cells were transfected with miR-133a-3p mimics and inhibitor then. The relative expression of miR-133a-3p was examined by real-time PCR after transfection, both of which showed significant transfection efficiency (Fig. 1B). Furthermore, to evaluate the redox state of H2O2-treated HTR-8/SVneo cells regulated by miR-133a-3p, cells were incubated with 250 μM H2O2 for 24 h after transfection for 24 h. From the results, the MDA levels were remarkably increased and enzyme activities of antioxidases SOD and GSH-Px were reduced markedly in the H2O2-treated HTR-8/SVneo cells compared to the control, but those alterations caused by H2O2 were suppressed significantly by miR-133a-3p overexpression (Fig. 1C). Besides, the ROS levels were also measured, in which H2O2 incubation of trophoblast cells increased relative ROS level and further miR-133a-3p upregulation dropped off its level but miR-133a-3p downregulation enhanced it (Fig. 1D). Therefore, these findings demonstrate that H2O2 treatment for HTR-8/SVneo cells reduces miR-133a-3p levels but increases BACH1 expression. MiR-133a-3p overexpression reverses the enhanced MDA and ROS levels and decreased antioxidase activities induced by H2O2 in HTR-8/SVneo cells while miR-133a-3p knockdown shows opposite effects.
MiR-133a-3p relieves the apoptosis induced by oxidative stress in HTR-8/SVneo cells
To study how miR-133a-3p affects trophoblast cell apoptosis induced by oxidative stress, cell viability was firstly assessed after cell transfection. It was shown that miR-133a-3p overexpression restored the reduction of H2O2-induced cell viability in HTR-8/SVneo cells, but miR-133a-3p knockdown exacerbated this effect and led to lower cell viability compared to the H2O2-exposed cells (Fig. 2A). Besides, overexpression of miR-133a-3p also attenuated the increased apoptosis rate induced by H2O2 in the trophoblast cells but miR-133a-3p knockdown enhanced it (Fig. 2B). The activities of caspase-3 and caspase-9 in HTR-8/SVneo cells were evaluated by their detection kits, which showed that miR-133a-3p overexpression alleviated the enhanced caspase activities induced by H2O2 (Fig. 2C). Moreover, WB was performed to detect protein levels of apoptosis-related indicators under the same condition. The results showed that the H2O2-caused elevated levels of pro-apoptosis protein Bax and cytoplasmic cytochrome C were reduced after miR-133a-3p upregulation, but enhanced when miR-133a-3p was knocked down (Fig. 2D, E). Meanwhile, alterations of protein levels of anti-apoptosis Bcl-2 and unreleased cytochrome C (mitochondria) were opposite in the H2O2-treated trophoblast cells after transfection (Fig. 2D, E). Furthermore, mitochondrial membrane potential in the cells was checked via a fluorescence probe JC-1. Since apoptotic cells would emit green fluorescence, it was found that miR-133a-3p overexpression significantly alleviated the H2O2-induced apoptotic cells but miR-133a-3p knockdown exacerbated cell apoptosis from oxidative stress (Fig. 2F). Hence, all these findings together suggest that miR-133a-3p can relieve the apoptosis induced by H2O2 in HTR-8/SVneo cells.
MiR-133a-3p targets BACH1 directly
To investigate certain related indicator involved in the miR-133a-3p regulations of trophoblast cell apoptosis induced by oxidative stress, a predicted target gene BACH1 of miR-133a-3p was studied. According to the online predicted binding sites of miR-133a-3p on 3′UTR of BACH1, dual luciferase reporter assay was performed to evaluate their target effects in HTR-8/SVneo cells. From the results, the cells co-transfected with wild type BACH1 3′UTR and miR-133a-3p mimics showed obviously lower luciferase activities compared to cells transfected with wild type BACH1 and NC mimics (Fig. 3), suggesting that miR-133a-3p could bind to BACH1 directly.
MiR-133a-3p regulates Nrf2/HO-1 signaling circuit in H2O2-treated HTR-8/SVneo cells through BACH1
Thereafter, real-time PCR and WB were carried out to detect relative expression of BACH1 in H2O2-treated HTR-8/SVneo cells after transfection at mRNA and protein levels, respectively. It was shown that miR-133a-3p upregulation reduced the elevated BACH1 expression caused by H2O2 treatment at both transcriptional and translational levels, while miR-133a-3p knockdown enhanced their expression significantly (Fig. 4A, B). Moreover, using WB analysis, nucleus and cytoplasmic Nrf2 and its downstream effector HO-1 were analyzed, which showed that compared to the increased nucleus Nrf2 and reduced cytoplasmic Nrf2 after H2O2 treatment, overexpressed miR-133a-3p exacerbated these effects and led more Nrf2 into the nucleus and less Nrf2 into the cytoplasm, while miR-133a-3p knockdown would restore these alterations (Fig. 4C). Besides, although H2O2 treatment more or less unchanged the HO-1 protein levels in the cells, miR-133a-3p overexpression enhanced its levels remarkably and knockdown of miR-133a-3p reduced them (Fig. 4C).
Moreover, to study whether BACH1 participates in the regulation of miR-133a-3p on the H2O2-treated HTR-8/SVneo cell apoptosis and Nrf2/HO-1 signaling, the cells were co-transfected with the miR-133a-3p mimics and BACH1-overexpressing plasmid. The transfected efficiency of BACH1 overexpression in HTR-8/SVneo cells was evaluated (Fig. 5A). It was shown that overexpressed BACH1 reversed the reduction of cell apoptosis rate and activities of caspase-3 and 9 mediated by miR-133a-3p mimics under H2O2 treatment (Fig. 5B, C). Besides, further upregulated BACH1 decreased the nucleus Nrf2 and further HO-1 expression level, which were enhanced by miR-133a-3p overexpression only in H2O2-treated HTR-8/SVneo cells (Fig. 5D). Since Nrf2/HO-1 signaling acts at the downstream of BACH1 to against oxidative stress, taken them together, it suggests that miR-133a-3p can regulate the HTR-8/SVneo cell apoptosis and also Nrf2/HO-1 signaling in response to oxidative stress induced by H2O2 through directly downregulating BACH1.
Discussion
Although particular factors to cause PE are still not precisely understood, the occurrence of PE is related to various pathophysiological pathways, in which abnormal placental function has been known to play a crucial role to induce PE (Lv et al. 2019). As abnormal trophoblast cell activities are largely related to placental dysfunction (Straszewski-Chavez et al. 2005), the studies involving trophoblast cell apoptosis seem to be significant for PE treatment. Meanwhile, it has been well-explored that the changes of several miRNAs in PE could regulate trophoblast function, mesenchymal stem cell effects and also angiogenesis (Lv et al. 2019). Here, our present study mainly investigated the regulation of miR-133a-3p on the trophoblast cell apoptosis induced by oxidative stress from H2O2, which may provide another potential target for PE-related therapy. Previous studies indicated that miR-133a-3p was downregulated in the H2O2-treated cardiomyocytes (Xu et al. 2014, Song et al. 2017). Combined with the antioxidative effects of miR-133a on the redox indicators in cardiomyocytes to respond to the oxidative stress induced by H2O2 (Xu et al. 2014), the present results also showed similar regulation of miR-133a-3p on the redox indicators to against oxidative stress in trophoblast cells as evidenced by enhanced antioxidases, but attenuated ROS and MDA levels.
Because of the antioxidant effects of miR-133a-3p under oxidative stress, overexpression of miR-133a-3p alleviated the increased apoptosis induced by H2O2 in trophoblast cells. Moreover, from the WB results of altered apoptotic indicators, it seemed that in HTR-8/SVneo cells, miR-133a-3p affected the intrinsic mitochondria-related apoptosis pathway to thereby regulate trophoblast cell apoptosis under oxidative stress. It is known that cytochrome C released from the mitochondria could induce apoptosis through activating downstream caspase-9 and subsequent caspase-3 activities (Li et al. 1997). Combined present findings with known mitochondria apoptotic pathway (Straszewski-Chavez et al. 2005), miR-133a-3p upregulation led to attenuated pro-apoptotic protein Bax levels which reduced the release of cytochrome C from mitochondria to cytoplasm without triggering more activities of caspase-9 and also its downstream caspase-3, resulting in alleviated apoptosis under oxidative stress in trophoblast cells. Interestingly, it has been reported that miR-133a-3p could target anti-apoptotic Bcl-xL and Mcl-1 directly in human osteosarcoma MG63 cells to promote cell apoptosis (Ji et al. 2013), which seemed to contradict our findings. And in esophageal cancers, miR-133a-3p was shown to target EGFR to promote cell apoptosis (Yang et al. 2017). Besides, it was also reported that miR-133a-3p induced apoptosis in gastric cancer cells through directly binding with IGF1R (Gong et al. 2015). Apart from cancers, miR-133a-3p was shown to inhibit hypoxia- and I/R injury-induced apoptosis in cardiomyocytes through targeting TAGLN2 and DAPK2 respectively (Li et al. 2015a, Li et al. 2015b). It seems that miR-133a-3p could act as a tumor suppressor in various cancers, but may also alleviate stress-induced apoptosis in other cell types, at least in cardiomyocytes and trophoblast cells from present study. MiR-133a-3p binds to other genes through multiple binding sites complementary to its seed sequence, which allows it to negatively regulate correlated genes and trigger off different signaling pathways in different cell types to respond to distinct stresses or disorders.
On the basis of the several published targets of miR-133a-3p, here, we studied another binding effect of miR-133a-3p on BACH1 which was regarded as a transcriptional repressor of Nrf2 to competitively inhibit its interactions with antioxidant response element (ARE) in the nucleus. In addition, in retinal ganglion cells, H2O2 treatment enhanced protein levels of BACH1, which was shown to negatively regulate downstream Nrf2 signaling to respond to oxidative stress (Jyrkkänen et al. 2011). Once cells were exposed to oxidative stress, free Nrf2 mainly dissociated from the Nrf2-Keap1 complex in the cytoplasm would translocate into the nucleus and bind to ARE to activate it, thereby regulating the activation of a range of antioxidant genes, including HMOX1 encoding HO-1 (Giudice et al. 2010, Jyrkkänen et al. 2011). From further WB analysis in present study, H2O2-treated trophoblast cells with miR-133a-3p overexpression reduced cytoplasm Nrf2 levels but Nrf2 in the nucleus was enhanced with elevated HO-1 protein expression to protect cells from the oxidative stress through downregulating BACH1. Moreover, further BACH1 overexpression also reversed the effects of miR-133a-3p mimics on the trophoblast cell apoptosis and Nrf2/HO-1 signaling under H2O2 treatment. Hence, a BACH1/Nrf2/HO-1 signaling pathway was found to be involved in the regulatory mechanisms of miR-133a-3p in the HTR-8/SVneo cells treated with H2O2 through directly binding effects on BACH1, which protected trophoblast cells against oxidative stress and undoubtedly oxidative stress-induced apoptosis.
In the initial pre-experiments, miR-133a-3p expression was reduced gradually over time in H2O2 incubated trophoblast cells, combined with increased BACH1 expression, so that longer exposure of H2O2 would decrease the miR-133a-3p levels which may induce less antioxidant gene activities and bring serious damages of cells from oxidative stress. Associated with the effects of miR-133a-3p overexpression under oxidative stress in the trophoblast cells, an exogenous regulation of miR-133a-3p might be useful to reverse the oxidative stress-induced damages of trophoblast cells. However, more pathological effects of it in the trophoblast cells should be explored and verified in vivo, which need more time and investigation in the future. Nevertheless, our findings at least proved the effects of miR-133a-3p to relieve the oxidative stress-induced trophoblast cell apoptosis, which may be considered as a choice for the treatment of PE-related trophoblastic diseases.
In conclusion, it is found that miR-133a-3p alleviates the oxidative stress induced by H2O2 in the HTR-8/SVneo cells and also attenuates the oxidative stress-induced cell apoptosis in trophoblast cells through an intrinsic mitochondrial apoptosis pathway. Dual luciferase assay indicates that miR-133a-3p directly targets 3′UTR of BACH1 and regulates BACH1 expression negatively. Meanwhile, miR-133a-3p overexpression enhances Nrf2/HO-1 signaling activity in the HTR-8/SVneo cells under oxidative stress through BACH1. Therefore, miR-133a-3p could relieve the oxidative stress-induced apoptosis by targeting BACH1 via regulating BACH1/Nrf2/HO-1 signaling pathway in the trophoblast cells, which provides a novel therapeutic perspective to target miR-133a-3p for the treatment of oxidative stress-induced trophoblast cell abnormality.
Acknowledgements
This study was supported by a grant from the Health Commission Project of Hebei Province (No. 20201059).
Footnotes
Conflict of Interest
There is no conflict of interest.
References
- ACKERMAN WE, BUHIMSCHI IA, EIDEM HR, RINKER DC, ROKAS A, ROOD K, ZHAO G, SUMMERFIELD TL, LANDON MB, BUHIMSCHI CS. Comprehensive RNA profiling of villous trophoblast and decidua basalis in pregnancies complicated by preterm birth following intra-amniotic infection. Placenta. 2016;44:23–33. doi: 10.1016/j.placenta.2016.05.010. [DOI] [PubMed] [Google Scholar]
- AL-JAMEIL N, AZIZ KHAN F, FAREED KHAN M, TABASSUM H. A brief overview of preeclampsia. J Clin Med Res. 2014;6:1–7. doi: 10.4021/jocmr1682w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GIUDICE A, ARRA C, TURCO MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol. 2010;647:37–74. doi: 10.1007/978-1-60761-738-9_3. [DOI] [PubMed] [Google Scholar]
- GONG Y, REN J, LIU K, TANG LM. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol. 2015;21:2949–2958. doi: 10.3748/wjg.v21.i10.2949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GROTEGUT CA. Prevention of preeclampsia. J Clin Invest. 2016;126:4396–4398. doi: 10.1172/JCI91300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HROMADNIKOVA I, KOTLABOVA K, IVANKOVA K, VEDMETSKAYA Y, KROFTA L. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction. Int J Cardiol. 2017;249:402–409. doi: 10.1016/j.ijcard.2017.07.045. [DOI] [PubMed] [Google Scholar]
- JI F, ZHANG H, WANG Y, LI M, XU W, KANG Y, WANG Z, WANG Z, CHENG P, TONG D, LI C, TANG H. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56:220–226. doi: 10.1016/j.bone.2013.05.020. [DOI] [PubMed] [Google Scholar]
- JYRKKÄNEN HK, KUOSMANEN S, HEINÄNIEMI M, LAITINEN H, KANSANEN E, MELLA-AHO E, LEINONEN H, YLÄ-HERTTUALA S, LEVONEN AL. Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2. Biochem J. 2011;440:167–174. doi: 10.1042/BJ20110526. [DOI] [PubMed] [Google Scholar]
- KUMAR D, LOU H, SINGAL PK. Oxidative stress and apoptosis in heart dysfunction. Herz. 2002;27:662–668. doi: 10.1007/s00059-002-2430-3. [DOI] [PubMed] [Google Scholar]
- LI AY, YANG Q, YANG K. miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes. Mol Cell Biochem. 2015a;400:173–181. doi: 10.1007/s11010-014-2273-2. [DOI] [PubMed] [Google Scholar]
- LI P, NIJHAWAN D, BUDIHARDJO I, SRINIVASULA SM, AHMAD M, ALNEMRI ES, WANG X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479–489. doi: 10.1016/S0092-8674(00)80434-1. [DOI] [PubMed] [Google Scholar]
- LI S, XIAO FY, SHAN PR, SU L, CHEN DL, DING JY, WANG ZQ. Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. J Hum Genet. 2015b;60 doi: 10.1038/jhg.2015.96. [DOI] [PubMed] [Google Scholar]
- LV Y, LU C, JI X, MIAO Z, LONG W, DING H, LV M. Roles of microRNAs in preeclampsia. J Cell Physiol. 2019;234:1052–1061. doi: 10.1002/jcp.27291. [DOI] [PubMed] [Google Scholar]
- MAJALI-MARTINEZ A, BARTH S, LANG U, DESOYE G, CERVAR-ZIVKOVIC M. Temporal changes of the endothelin system in human cytotrophoblasts during the first trimester of pregnancy. Physiol Res. 2018;67(Suppl 1):S247–S255. doi: 10.33549/physiolres.933828. [DOI] [PubMed] [Google Scholar]
- MOL BWJ, ROBERTS CT, THANGARATINAM S, MAGEE LA, De GROOT CJM, HOFMEYR GJ. Pre-eclampsia. Lancet. 2016;387:999–1011. doi: 10.1016/S0140-6736(15)00070-7. [DOI] [PubMed] [Google Scholar]
- PU M, CHEN J, TAO Z, MIAO L, QI X, WANG Y, REN J. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci. 2019;76:441–451. doi: 10.1007/s00018-018-2940-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REN L, WANG Q, CHEN Y, MA Y, WANG D. Involvement of microRNA-133a in the protective effect of hydrogen sulfide against ischemia/reperfusion-induced endoplasmic reticulum stress and cardiomyocyte apoptosis. Pharmacology. 2019;103:1–9. doi: 10.1159/000492969. [DOI] [PubMed] [Google Scholar]
- SIBAI BM, STELLA CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol. 2009;200:481.e481–487. doi: 10.1016/j.ajog.2008.07.048. [DOI] [PubMed] [Google Scholar]
- SONG T, YAO Y, WANG T, HUANG H, XIA H. Tanshinone IIA ameliorates apoptosis of myocardiocytes by up-regulation of miR-133 and suppression of caspase-9. Eur J Pharmacol. 2017;815:343–350. doi: 10.1016/j.ejphar.2017.08.041. [DOI] [PubMed] [Google Scholar]
- STRASZEWSKI-CHAVEZ SL, ABRAHAMS VM, MOR G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev. 2005;26:877–897. doi: 10.1210/er.2005-0003. [DOI] [PubMed] [Google Scholar]
- UCHIDA Y, CHIYOMARU T, ENOKIDA H, KAWAKAMI K, TATARANO S, KAWAHARA K, NISHIYAMA K, SEKI N, NAKAGAWA M. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol. 2013;31:115–123. doi: 10.1016/j.urolonc.2010.09.017. [DOI] [PubMed] [Google Scholar]
- XU C, HU Y, HOU L, JU J, LI X, DU N, GUAN X, LIU Z, ZHANG T, QIN W, SHEN N, BILAL MU, LU Y, ZHANG Y, SHAN H. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression. J Mol Cell Cardiol. 2014;75:111–121. doi: 10.1016/j.yjmcc.2014.07.009. [DOI] [PubMed] [Google Scholar]
- YANG H, HE X, WANG C, ZHANG L, YU J, WANG K. Knockdown of TUG 1 suppresses hypoxia-induced apoptosis of cardiomyocytes by up-regulating miR-133a. Arch Biochem Biophys. 2020;681:108262. doi: 10.1016/j.abb.2020.108262. [DOI] [PubMed] [Google Scholar]
- YANG QS, JIANG LP, HE CY, TONG YN, LIU YY. Up-regulation of microRNA-133a inhibits the MEK/ERK signaling pathway to promote cell apoptosis and enhance radio-sensitivity by targeting EGFR in esophageal cancer in vivo and in vitro. J Cell Biochem. 2017;118:2625–2634. doi: 10.1002/jcb.25829. [DOI] [PubMed] [Google Scholar]
- YIN Y, DU L, LI X, ZHANG X, GAO Y. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma. J Cell Physiol. 2019;234:12757–12770. doi: 10.1002/jcp.27896. [DOI] [PubMed] [Google Scholar]
- YU L, LI D, LIAO QP, YANG HX, CAO B, FU G, YE G, BAI Y, WANG H, CUI N, LIU M, LI YX, LI J, PENG C, WANG YL. High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling. J Clin Endocrinol Metab. 2012;97:E1370–E1379. doi: 10.1210/jc.2011-2729. [DOI] [PubMed] [Google Scholar]